Scientific Reports (Feb 2024)

Mesenchymal stem cells-derived extracellular vesicles for therapeutics of renal tuberculosis

  • Natalia Yudintceva,
  • Danila Bobkov,
  • Maksim Sulatsky,
  • Natalia Mikhailova,
  • Elena Oganesyan,
  • Tatiana Vinogradova,
  • Alexandr Muraviov,
  • Anna Remezova,
  • Evdokia Bogdanova,
  • Irina Garapach,
  • Olga Maslak,
  • Dilyara Esmedlyaeva,
  • Marina Dyakova,
  • Petr Yablonskiy,
  • Rustam Ziganshin,
  • Sergey Kovalchuk,
  • Natalya Blum,
  • Shirish H. Sonawane,
  • Avinash Sonawane,
  • Ankita Behl,
  • Shailja Singh,
  • Maxim Shevtsov

DOI
https://doi.org/10.1038/s41598-024-54992-z
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 15

Abstract

Read online

Abstract Extrapulmonary tuberculosis with a renal involvement can be a manifestation of a disseminated infection that requires therapeutic intervention, particularly with a decrease in efficacy of conventional regimens. In the present study, we investigated the therapeutic potency of mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) in the complex anti-tuberculosis treatment (ATT). A rabbit model of renal tuberculosis (rTB) was constructed by injecting of the standard strain Mycobacterium tuberculosis H37Rv into the cortical layer of the kidney parenchyma. Isolated rabbit MSC-EVs were intravenously administered once as an addition to standard ATT (isoniazid, pyrazinamide, and ethambutol). The therapeutic efficacy was assessed by analyzing changes of blood biochemical biomarkers and levels of anti- and pro-inflammatory cytokines as well as by renal computed tomography with subsequent histological and morphometric examination. The therapeutic effect of therapy with MSC-EVs was shown by ELISA method that confirmed a statistically significant increase of the anti-inflammatory and decrease of pro-inflammatory cytokines as compared to conventional treatment. In addition, there is a positive trend in increase of ALP level, animal weigh, and normalization of ADA activity that can indicate an improvement of kidney state. A significant reduction of the area of specific and interstitial inflammation indicated positive affect of MSC-EVs that suggests a shorter duration of ATT. The number of MSC-EVs proteins (as identified by mass-spectometry analysis) with anti-microbial, anti-inflammatory and immunoregulatory functions reduced the level of the inflammatory response and the severity of kidney damage (further proved by morphometric analysis). In conclusion, MSC-EVs can be a promising tool for the complex treatment of various infectious diseases, in particularly rTB.

Keywords